TGA Approval

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 3 micrograms/0.3 mL concentrated suspension for injection multidose vial (428610)

ARTG ID

428610

ARTG Name

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 3 micrograms/0.3 mL concentrated suspension for injection multidose vial

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

December 22, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/6e393674caf909bb76d5374335ba9e63.pdf

https://medical-cdn.nocode.com/drug_tga/a3a7c889e756272030f6c7533576b6f9.pdf

Ingredient Name

raxtozinameran

Empowering clinical research with data-driven insights and AI-powered tools.